Skip to main content
Fig. 1 | BMC Complementary and Alternative Medicine

Fig. 1

From: Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos

Fig. 1

Effects of different doses of A. marmelos extract on OGTT in STZ-induced diabetic rats. A. marmelos extract was administered orally 60 min before glucose (3 g/kg body weight) loading. Blood was sampled from the tail vein at −60 (before A. marmelos extracts and glibenclamide) and at 0, 30, 60, 120, and 180 min after glucose load. Data represent mean ± SEM for 6–9 rats in each group. Db, diabetic rats treated with glucose only; GB, diabetic rats treated with glucose plus glibenclamide (5 mg/kg); AM 200, AM 400 and AM 600, diabetic rats treated with glucose plus A. marmelos extract of 200, 400, 600 mg/kg, respectively. *p < 0.05 compared with the corresponding values of vehicle group of Db rats (two-way ANOVA with Dunnett’s multicomparison test)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us